Nandrolone phenpropionate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for nandrolone phenpropionate and what is the scope of patent protection?
Nandrolone phenpropionate
is the generic ingredient in two branded drugs marketed by Organon Usa Inc and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for nandrolone phenpropionate.
Summary for nandrolone phenpropionate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Patent Applications: | 4,489 |
| DailyMed Link: | nandrolone phenpropionate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for nandrolone phenpropionate
US Patents and Regulatory Information for nandrolone phenpropionate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 086386-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Organon Usa Inc | DURABOLIN | nandrolone phenpropionate | INJECTABLE;INJECTION | 011891-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | NANDROLONE PHENPROPIONATE | nandrolone phenpropionate | INJECTABLE;INJECTION | 087488-001 | Jun 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
